1
|
Misbah MH, Quintanilla-Sierra L, Alonso M, Rodríguez-Cabello JC, Santos M. "In-situ" formation of elastin-like recombinamer hydrogels with tunable viscoelasticity through efficient one-pot process. Mater Today Bio 2024; 25:100999. [PMID: 38379933 PMCID: PMC10877175 DOI: 10.1016/j.mtbio.2024.100999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2023] [Revised: 02/08/2024] [Accepted: 02/09/2024] [Indexed: 02/22/2024] Open
Abstract
Despite the remarkable progress in the generation of recombinant elastin-like (ELR) hydrogels, further improvements are still required to enhance and control their viscoelasticity, as well as limit the use of expensive chemical reagents, time-consuming processes and several purification steps. To alleviate this issue, the reactivity of carboxylic groups from glutamic (E) acid distributed along the hydrophilic block of an amphiphilic ELR (coded as E50I60) with amine groups has been studied through a one-pot amidation reaction in aqueous solutions, for the first time. By means of this approach, immediate conjugation of E50I60 with molecules containing amine groups has been performed with a high yield, as demonstrated by the 1H NMR and MALDI-TOF spectroscopies. This has resulted in the preparation of viscoelastic irreversible hydrogels through the "in-situ" cross-linking of E50I60 with another ELR (coded as VKV24) containing amine groups from lysines (K). The rheology analysis demonstrated that the gelation process takes place following a dual mechanism dependent on the ELR concentration: physical cross-linking of I60 block through the hydrophobic interactions, and covalent cross-linking of E50I60 with VKV24 through the amidation reaction. While the chemical network formed between the hydrophilic E50 block and VKV24 ELR preserves the elasticity of ELR hydrogels, the self-assembly of the I60 block through the hydrophobic interactions provides a tunable physical network. The presented investigation serves as a basis for generating ELR hydrogels with tunable viscoelastic properties promising for tissue regeneration, through an ''in-situ", rapid, scalable, economically and feasible one-pot method.
Collapse
Affiliation(s)
- M. Hamed Misbah
- Nanoscience Department, Institute of Nanoscience & Nanotechnology, Kafrelsheikh University, Kafrelsheikh, 33511, Egypt
| | - Luis Quintanilla-Sierra
- G.I.R. Bioforge, University of Valladolid, CIBER-BBN, Paseo de Belén 19, 47011, Valladolid, Spain
| | - Matilde Alonso
- G.I.R. Bioforge, University of Valladolid, CIBER-BBN, Paseo de Belén 19, 47011, Valladolid, Spain
| | | | - Mercedes Santos
- G.I.R. Bioforge, University of Valladolid, CIBER-BBN, Paseo de Belén 19, 47011, Valladolid, Spain
| |
Collapse
|
2
|
Alonso M, Villanego F, Segurado Ó, Vigara LA, Orellana C, García T, Mazuecos A. De novo IgA nephropathy in a kidney transplant recipient after SARS-CoV-2 vaccination. Nefrologia 2024; 44:277-279. [PMID: 38641488 DOI: 10.1016/j.nefroe.2024.03.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/21/2024] Open
Affiliation(s)
- M Alonso
- Servicio de Nefrología, Hospital Universitario Puerta del Mar, Cádiz, Spain.
| | - F Villanego
- Servicio de Nefrología, Hospital Universitario Puerta del Mar, Cádiz, Spain.
| | - Ó Segurado
- Servicio de Nefrología, Hospital Universitario Puerta del Mar, Cádiz, Spain.
| | - L A Vigara
- Servicio de Nefrología, Hospital Universitario Puerta del Mar, Cádiz, Spain.
| | - C Orellana
- Servicio de Nefrología, Hospital Universitario Puerta del Mar, Cádiz, Spain.
| | - T García
- Servicio de Nefrología, Hospital Universitario Puerta del Mar, Cádiz, Spain.
| | - A Mazuecos
- Servicio de Nefrología, Hospital Universitario Puerta del Mar, Cádiz, Spain.
| |
Collapse
|
3
|
Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda E, Gironés R, Fuster J, Hong W, Dumas M, Gill S, Navarro LM, Herrero A, Dowling A, de Las Peñas R, Vaz MA, Alonso M, Lwin Z, Harrup R, Peralta S, Long A, Perez-Segura P, Ahern E, Garate CO, Wong M, Campbell R, Cuff K, Jennens R, Gallego O, Underhill C, Martinez-Garcia M, Covela M, Cooper A, Brown S, Rosenthal M, Torres J, Collins IM, Gibbs P, Balana C. Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma. J Neurooncol 2024; 166:417-418. [PMID: 38289531 DOI: 10.1007/s11060-024-04581-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2024]
Affiliation(s)
- L Gately
- Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
- Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia.
| | - C Mesía
- Medical Oncology Service, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain
| | - J M Sepúlveda
- Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - S Del Barco
- Medical Oncology Service, Institut Català d'Oncologia Girona, Girona, Spain
| | - E Pineda
- Medical Oncology Service, Hospital Clinic de Barcelona, Barcelona, Spain
| | - R Gironés
- Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain
| | - J Fuster
- Medical Oncology Service, Hospital Son Espases, Palma de Mallorca, Spain
| | - W Hong
- Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
| | - M Dumas
- Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
| | - S Gill
- Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia
| | - L M Navarro
- Medical Oncology Service, Hospital de Salamanca, Salamanca, Spain
| | - A Herrero
- Medical Oncology Service, Hospital Miguel Servet, Zaragoza, Spain
| | - A Dowling
- Department of Medical Oncology, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia
| | - R de Las Peñas
- Medical Oncology Service, Hospital Provincial de Castellón, Castellón, Spain
| | - M A Vaz
- Medical Oncology Service, Hospital Ramón y Cajal, Madrid, Spain
| | - M Alonso
- Medical Oncology Service, Hospital Virgen del Rocio, Seville, Spain
| | - Z Lwin
- Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
| | - R Harrup
- Department of Medical Oncology, Royal Hobart Hospital, Hobart, TAS, Australia
| | - S Peralta
- Medical Oncology Service, Hospital Sant Joan de Reus, Reus, Spain
| | - A Long
- Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia
| | - P Perez-Segura
- Medical Oncology Service, Hospital Clinico San Carlos, Madrid, Spain
| | - E Ahern
- Department of Medical Oncology, Monash Health, Melbourne, VIC, Australia
| | - C O Garate
- Medical Oncology Service, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain
| | - M Wong
- Department of Medical Oncology, Westmead Hospital, Westmead, NSW, Australia
| | - R Campbell
- Department of Medical Oncology, Bendigo Health, Bendigo, VIC, Australia
| | - K Cuff
- Department of Medical Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia
| | - R Jennens
- Department of Medical Oncology, Epworth Health, Richmond, VIC, Australia
| | - O Gallego
- Medical Oncology Service, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain
| | - C Underhill
- Department of Medical Oncology, Border Medical Oncology, East Albury, NSW, Australia
| | | | - M Covela
- Medical Oncology Service, Hospital Lucus Augusti, Lugo, Spain
| | - A Cooper
- Department of Medical Oncology, Liverpool Hospital, Liverpool, NSW, Australia
| | - S Brown
- Department of Medical Oncology, Ballarat Health Services, Ballarat, VIC, Australia
| | - M Rosenthal
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
| | - J Torres
- Department of Medical Oncology, Goulburn Valley Health, Shepparton, VIC, Australia
| | - I M Collins
- Department of Medical Oncology, South West Regional Cancer Centre, Geelong, VIC, Australia
| | - P Gibbs
- Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
| | - C Balana
- Medical Oncology Service, Institut Català d'Oncologia, Badalona, Spain
- Badalona Applied Research Group in Oncology (B-ARGO), Institut Investigació Germans Trias I Pujol (IGTP), Badalona, Spain
| |
Collapse
|
4
|
Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda E, Gironés R, Fuster J, Hong W, Dumas M, Gill S, Navarro LM, Herrero A, Dowling A, de Las Peñas R, Vaz MA, Alonso M, Lwin Z, Harrup R, Peralta S, Long A, Perez-Segura P, Ahern E, Garate CO, Wong M, Campbell R, Cuff K, Jennens R, Gallego O, Underhill C, Martinez-Garcia M, Covela M, Cooper A, Brown S, Rosenthal M, Torres J, Collins IM, Gibbs P, Balana C. A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma. J Neurooncol 2024; 166:407-415. [PMID: 38153582 DOI: 10.1007/s11060-023-04513-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Accepted: 11/15/2023] [Indexed: 12/29/2023]
Abstract
PURPOSE The optimal duration of post-radiation temozolomide in newly diagnosed glioblastoma remains unclear, with no published phase III randomised trials. Standard-of-care stipulates 6 months. However, in routine care, it is often extended to 12 months, despite lacking robust supporting data. METHODS GEINO14-01 (Spain) and EX-TEM (Australia) studies enrolled glioblastoma patients without progression at the end of 6 months post-radiation temozolomide. Participants were randomised 1:1 to six additional months of temozolomide or observation. Primary endpoint was 6-month progression free survival from date of randomisation (6mPFS). Secondary endpoints included overall survival (OS) and toxicity. 204 patients were required to detect an improvement in 6mPFS from 50 to 60% (80% power). Neither study recruited sufficient patients. We performed a combined analysis of individual patient data. RESULTS 205 patients were recruited: 159 in GEINO14-01 (2014-2018) and 46 in EX-TEM (2019-2022). Median follow-up was 20.0 and 14.5 months. Baseline characteristics were balanced. There was no significant improvement in 6mPFS (57.2% vs 64.0%, OR0.75, p = 0.4), nor across any subgroups, including MGMT methylated; PFS (HR0.92, p = 0.59, median 7.8 vs 9.7 months); or OS (HR1.03, p = 0.87, median 20.1 vs 19.4 months). During treatment extension, 64% experienced any grade adverse event, mainly fatigue and gastrointestinal (both 54%). Only a minority required treatment changes: 4.5% dose delay, 7.5% dose reduction, 1.5% temozolomide discontinuation. CONCLUSION For glioblastoma patients, extending post-radiation temozolomide from 6 to 12 months is well tolerated but does not improve 6mPFS. We could not identify any subset that benefitted from extended treatment. Six months should remain standard-of-care.
Collapse
Affiliation(s)
- L Gately
- Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
- Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia.
| | - C Mesía
- Medical Oncology Service, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain
| | - J M Sepúlveda
- Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - S Del Barco
- Medical Oncology Service, Institut Català d'Oncologia Girona, Girona, Spain
| | - E Pineda
- Medical Oncology Service, Hospital Clinic de Barcelona, Barcelona, Spain
| | - R Gironés
- Medical Oncology Service, Hospital Universitario La Fe, Valencia, Spain
| | - J Fuster
- Medical Oncology Service, Hospital Son Espases, Palma de Mallorca, Spain
| | - W Hong
- Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
| | - M Dumas
- Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
| | - S Gill
- Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia
| | - L M Navarro
- Medical Oncology Service, Hospital de Salamanca, Salamanca, Spain
| | - A Herrero
- Medical Oncology Service, Hospital Miguel Servet, Zaragoza, Spain
| | - A Dowling
- Department of Medical Oncology, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia
| | - R de Las Peñas
- Medical Oncology Service, Hospital Provincial de Castellón, Castellón, Spain
| | - M A Vaz
- Medical Oncology Service, Hospital Ramón y Cajal, Madrid, Spain
| | - M Alonso
- Medical Oncology Service, Hospital Virgen del Rocio, Seville, Spain
| | - Z Lwin
- Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
| | - R Harrup
- Department of Medical Oncology, Royal Hobart Hospital, Hobart, TAS, Australia
| | - S Peralta
- Medical Oncology Service, Hospital Sant Joan de Reus, Reus, Spain
| | - A Long
- Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia
| | - P Perez-Segura
- Medical Oncology Service, Hospital Clinico San Carlos, Madrid, Spain
| | - E Ahern
- Department of Medical Oncology, Monash Health, Melbourne, VIC, Australia
| | - C O Garate
- Medical Oncology Service, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain
| | - M Wong
- Department of Medical Oncology, Westmead Hospital, Westmead, NSW, Australia
| | - R Campbell
- Department of Medical Oncology, Bendigo Health, Bendigo, VIC, Australia
| | - K Cuff
- Department of Medical Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia
| | - R Jennens
- Department of Medical Oncology, Epworth Health, Richmond, VIC, Australia
| | - O Gallego
- Medical Oncology Service, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
| | - C Underhill
- Department of Medical Oncology, Border Medical Oncology, East Albury, NSW, Australia
| | | | - M Covela
- Medical Oncology Service, Hospital Lucus Augusti, Lugo, Spain
| | - A Cooper
- Department of Medical Oncology, Liverpool Hospital, Liverpool, NSW, Australia
| | - S Brown
- Department of Medical Oncology, Ballarat Health Services, Ballarat, VIC, Australia
| | - M Rosenthal
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
| | - J Torres
- Department of Medical Oncology, Goulburn Valley Health, Shepparton, VIC, Australia
| | - I M Collins
- Department of Medical Oncology, South West Regional Cancer Centre, Geelong, VIC, Australia
| | - P Gibbs
- Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
| | - C Balana
- Medical Oncology Service, Institut Català d'Oncologia, Badalona, Spain
- Badalona Applied Research Group in Oncology (B-ARGO), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain
| |
Collapse
|
5
|
Toribio-Vazquez C, Cansino R, Fernández-Pascual E, Eguibar A, Ayllon H, Solano-Heranz P, Perez-Carral J, Mainez J, Giron M, Rodriguez A, Yebes A, Alonso M, Martínez S, Martínez-Piñeiro L. Comparing the use of AquaBeam® and HoLEP for the treatment of patients with benign prostatic hyperplasia. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01165-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
6
|
Rodríguez-Almaraz E, Gutiérrez-Solís E, Rabadán E, Rodríguez P, Alonso M, Carmona L, de Yébenes MJG, Morales E, Galindo-Izquierdo M. Searching for a prognostic index in lupus nephritis. Eur J Med Res 2023; 28:19. [PMID: 36631838 PMCID: PMC9832788 DOI: 10.1186/s40001-022-00946-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Accepted: 12/11/2022] [Indexed: 01/13/2023] Open
Abstract
BACKGROUND Currently we do not have an ideal biomarker in lupus nephritis (LN) that should help us to identify those patients with SLE at risk of developing LN or to determine those patients at risk of renal progression. We aimed to evaluate the development of a prognostic index for LN, through the evaluation of clinical, analytical and histological factors used in a cohort of lupus. We have proposed to determine which factors, 6 months after the diagnosis of LN, could help us to define which patients will have a worse evolution of the disease and may be, more aggressive treatment and closer follow-up. METHODS A retrospective study to identify prognostic factors was carried out. We have included patients over 18 years of age with a clinical diagnosis of systemic lupus erythematosus (SLE) and kidney involvement confirmed by biopsy, who are followed up in our centre during the last 20 years. A multi-step statistical approach will be used in order to obtain a limited set of parameters, optimally selected and weighted, that show a satisfactory ability to discriminate between patients with different levels of prognosis. RESULTS We analysed 92 patients with LN, although only 73 have been able to be classified according to whether or not they have presented poor renal evolution. The age of onset (44 vs. 32; p = 0.024), the value of serum creatinine (1.41 vs. 1.04; p = 0.041), greater frequency of thrombocytopenia (30 vs. 7%; p = 0.038), higher score in the renal chronicity index (2.47 vs. 1.04; p = 0.015), proliferative histological type (100%) and higher frequency of interstitial fibrosis (67 vs. 32%; p = 0.017) and tubular atrophy (67 vs. 32%; p = 0.018) was observed between two groups. The multivariate analysis allowed us to select the best predictive model for poor outcome at 6 months based on different adjustment and discrimination parameters. CONCLUSION We have developed a prognostic index of poor renal evolution in patients with LN that combines demographic, clinical, analytical and histopathological factors, easy to use in routine clinical practice and that could be an effective tool in the early detection and management.
Collapse
Affiliation(s)
- E. Rodríguez-Almaraz
- grid.144756.50000 0001 1945 5329Department of Rheumatology, University Hospital “12 de Octubre”, Avda. Córdoba Km 5.400, 28041 Madrid, Spain ,grid.144756.50000 0001 1945 5329Research Institute of University Hospital “12 de Octubre” (imas12), Madrid, Spain
| | - E. Gutiérrez-Solís
- grid.144756.50000 0001 1945 5329Department of Nephrology, University Hospital “12 de Octubre”, Madrid, Spain ,grid.144756.50000 0001 1945 5329Research Institute of University Hospital “12 de Octubre” (imas12), Madrid, Spain
| | - E. Rabadán
- grid.144756.50000 0001 1945 5329Department of Rheumatology, University Hospital “12 de Octubre”, Avda. Córdoba Km 5.400, 28041 Madrid, Spain
| | - P. Rodríguez
- grid.144756.50000 0001 1945 5329Department of Nephrology, University Hospital “12 de Octubre”, Madrid, Spain
| | - M. Alonso
- grid.144756.50000 0001 1945 5329Department of Pathology, University Hospital “12 de Octubre”, Madrid, Spain
| | - L. Carmona
- grid.489005.0Instituto de Salud Musculoesquelética (Inmusc), Madrid, Spain
| | | | - E. Morales
- grid.144756.50000 0001 1945 5329Department of Nephrology, University Hospital “12 de Octubre”, Madrid, Spain ,grid.144756.50000 0001 1945 5329Research Institute of University Hospital “12 de Octubre” (imas12), Madrid, Spain ,grid.4795.f0000 0001 2157 7667 Department of Medicine, Complutense University, Madrid, Spain
| | - M. Galindo-Izquierdo
- grid.144756.50000 0001 1945 5329Department of Rheumatology, University Hospital “12 de Octubre”, Avda. Córdoba Km 5.400, 28041 Madrid, Spain ,grid.144756.50000 0001 1945 5329Research Institute of University Hospital “12 de Octubre” (imas12), Madrid, Spain ,grid.4795.f0000 0001 2157 7667 Department of Medicine, Complutense University, Madrid, Spain
| |
Collapse
|
7
|
Alonso M, Villanego F, Orellana C, Vigara L, Montiel N, Aguilera A, Amaro J, Garcia T, Mazuecos A. Impact of BK Polyomavirus Plasma Viral Load in Kidney Transplant Outcomes. Transplant Proc 2022; 54:2457-2461. [DOI: 10.1016/j.transproceed.2022.10.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2022] [Accepted: 10/01/2022] [Indexed: 11/24/2022]
|
8
|
González-Pérez F, Alonso M, González de Torre I, Santos M, Rodríguez-Cabello JC. Protease-Sensitive, VEGF-Mimetic Peptide, and IKVAV Laminin-Derived Peptide Sequences within Elastin-Like Recombinamer Scaffolds Provide Spatiotemporally Synchronized Guidance of Angiogenesis and Neurogenesis. Adv Healthc Mater 2022; 11:e2201646. [PMID: 36099430 DOI: 10.1002/adhm.202201646] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2022] [Revised: 08/29/2022] [Indexed: 01/28/2023]
Abstract
Spatiotemporal control of vascularization and innervation is a desired hallmark in advanced tissue regeneration. For this purpose, we design a 3D model scaffold, based on elastin-like recombinamer (ELR) hydrogels. This contains two interior and well-defined areas, small cylinders, with differentiated bioactivities with respect to the bulk. Both are constructed on a protease sensitive ELR with a fast-proteolyzed domain, but one bears a VEGF-mimetic peptide (QK) and the other a laminin-derived pentapeptide (IKVAV), to promote angiogenesis and neurogenesis, respectively. The outer bulk is based on a slow proteolytic sequence and RGD cell adhesion domains. In vitro studies show the effect of QK and IKVAV peptides on the promotion of endothelial cell and axon spreading, respectively. The subcutaneous implantation of the final 3D scaffold demonstrates the ability to spatiotemporally control angiogenesis and neurogenesis in vivo. Specifically, the inner small cylinder containing the QK peptide promotes fast endothelialization, whereas the one with IKVAV peptide promotes fast neurogenesis. Both, vascularization and innervation take place in advance of the bulk scaffold infiltration. This scaffold shows that it is possible to induce vascularization and innervation in predetermined areas of the scaffold well ahead to the bulk infiltration. That significantly increases the efficiency of the regenerative activity.
Collapse
Affiliation(s)
- Fernando González-Pérez
- G.I.R. BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, Edificio LUCIA, Universidad de Valladolid, Paseo Belén 19, Valladolid, 47011, Spain
| | - Matilde Alonso
- G.I.R. BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, Edificio LUCIA, Universidad de Valladolid, Paseo Belén 19, Valladolid, 47011, Spain
| | - Israel González de Torre
- G.I.R. BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, Edificio LUCIA, Universidad de Valladolid, Paseo Belén 19, Valladolid, 47011, Spain
| | - Mercedes Santos
- G.I.R. BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, Edificio LUCIA, Universidad de Valladolid, Paseo Belén 19, Valladolid, 47011, Spain
| | - José Carlos Rodríguez-Cabello
- G.I.R. BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, Edificio LUCIA, Universidad de Valladolid, Paseo Belén 19, Valladolid, 47011, Spain
| |
Collapse
|
9
|
González‐Pérez F, Alonso M, González de Torre I, Santos M, Rodríguez‐Cabello JC. Protease‐Sensitive, VEGF‐Mimetic Peptide, and IKVAV Laminin‐Derived Peptide Sequences within Elastin‐Like Recombinamer Scaffolds Provide Spatiotemporally Synchronized Guidance of Angiogenesis and Neurogenesis (Adv. Healthcare Mater. 22/2022). Adv Healthc Mater 2022. [DOI: 10.1002/adhm.202270132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
10
|
Schmitz B, Wirtz S, Sestayo-Fernandez M, Schaefer H, Douma ER, Alonso M, Gonzalez-Salvado V, Habibovic M, Kop WJ, Pena-Gil C, Mooren FC. Defining patients needs and expectations for eHealth-based cardiac rehabilitation in Germany and Spain: living lab data from the TIMELY study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2828] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
eHealth innovations have set the stage to optimize personalized care and provide assistance for disease control to patients with CAD. TIMELY is the first artificial intelligence (AI)-driven eHealth approach that employs internet of things devices and is based on cardiac rehabilitation (CR) components. To guarantee acceptance and usability of eHealth solutions, patients are actively participating in development through a Living Lab approach.
Purpose
To define patients' needs for an eHealth-based lifestyle intervention and self-care support.
Methods
The Living Lab approach included a guided survey conducted among CAD patients at CR centers in Germany and Spain during inpatient or outpatient CR, respectively. Questions referred to current use of technology and patients' opinion on the usefulness of suggested features of a future eHealth application. Ratings for usefulness/importance were recorded on a 5-point Likert scale reported as median score.
Results
79 patients (20% female) were interviewed (DE, n=49; ES, n=30). Patients' mean age was 57 years (range 37–79), educational level was 87% ≤ high school and 13% > high school. All patients owned a smartphone that they also used for information (76%) and documentation (43%). Patients rated the importance of all CR components (regular exercise, healthy diet, stress management, smoking cessation, risk factor reduction) along the continuum of care as “very high” (5/5). Individual need for regular exercise support after structured CR was rated “high” (4/5). Exercise reminders, suggestions on activities, update of recommended training heart rate, evaluation of training progress, and achieved goals were rated “useful” (4/5) to “very useful” (5/5). The importance of support for diet, stress management, overall risk factor management, and medication was rated 3/5. Usefulness of a learning/education tool was rated 4/5, while motivational messages scored 3/5 and individual feedback of a person or virtual agent scored 4/5 and 3/5, respectively. The availability of electronic health records was evaluated as “very useful” (5/5) remote ECG monitoring and blood pressure management were rated as “useful” (4/5). The range of all items accessed was 1–5, indicating large interindividual differences. No significant differences existed between female and male patients or German and Spanish patients, though the importance of sharing training progress with family/ friends was rated higher by men (3/5) compared to women (1/5) and higher by Spanish (4/5) compared to German patients (2/5).
Conclusions
CR patients expressed a strong need for individual support of regular physical exercise and updated training recommendations. The observed inter-individual differences regarding usefulness and acceptance indicate the need for a highly adaptive system to prevent exclusion from eHealth access. CR patients from Germany and Spain showed equally high acceptance of eHealth components for the management of CAD.
Funding Acknowledgement
Type of funding sources: Public grant(s) – EU funding. Main funding source(s): European Commission Horizon 2020
Collapse
Affiliation(s)
- B Schmitz
- University of Witten/Herdecke, Department of Rehabilitation Sciences , Witten , Germany
| | - S Wirtz
- University of Witten/Herdecke, Department of Rehabilitation Sciences , Witten , Germany
| | - M Sestayo-Fernandez
- University Hospital of Santiago de Compostela, Cardiology and Coronary Care Department , Santiago de Compostela , Spain
| | - H Schaefer
- University of Witten/Herdecke, Department of Rehabilitation Sciences , Witten , Germany
| | - E R Douma
- Center of Research on Psychology in Somatic diseases at Tilburg University, Department of Medical and Clinical Psychology , Tilburg , The Netherlands
| | - M Alonso
- University Hospital of Santiago de Compostela, Cardiology and Coronary Care Department , Santiago de Compostela , Spain
| | - V Gonzalez-Salvado
- University Hospital of Santiago de Compostela, Cardiology and Coronary Care Department , Santiago de Compostela , Spain
| | - M Habibovic
- Center of Research on Psychology in Somatic diseases at Tilburg University, Department of Medical and Clinical Psychology , Tilburg , The Netherlands
| | - W J Kop
- Center of Research on Psychology in Somatic diseases at Tilburg University, Department of Medical and Clinical Psychology , Tilburg , The Netherlands
| | - C Pena-Gil
- University Hospital of Santiago de Compostela, Cardiology and Coronary Care Department , Santiago de Compostela , Spain
| | - F C Mooren
- University of Witten/Herdecke, Department of Rehabilitation Sciences , Witten , Germany
| |
Collapse
|
11
|
Hernandez S, Rodriguez Carrillo J, Caminoa A, Benito A, Martinez R, Alonso M, Clave S, Arriola E, Esteban-Rodriguez I, De Castro J, Sansano I, Felip E, Abdulkader I, Garcia J, Rojo F, Domine M, Teixido C, Reguart N, Compañ D, Insa A, Mancheño N, Palanca S, Juan O, Baixeras N, Nadal E, Cebollero M, Calles A, Martin P, Salas C, Provencio M, Aranda I, Massuti B, Lopez-Vilaro L, Majem M, Garrido P, Paz-Ares L, Lopez-Rios F, Conde E. P2.07-02 RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
12
|
Ibáñez-Fonseca A, Rico A, Preciado S, González-Pérez F, Muntión S, García-Briñón J, García-Macías MC, Rodríguez-Cabello JC, Pericacho M, Alonso M, Sánchez-Guijo F. Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia. Front Bioeng Biotechnol 2022; 10:918602. [PMID: 35814011 PMCID: PMC9260019 DOI: 10.3389/fbioe.2022.918602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2022] [Accepted: 05/16/2022] [Indexed: 12/03/2022] Open
Abstract
Hindlimb ischemia is an unmet medical need, especially for those patients unable to undergo vascular surgery. Cellular therapy, mainly through mesenchymal stromal cell (MSC) administration, may be a potentially attractive approach in this setting. In the current work, we aimed to assess the potential of the combination of MSCs with a proangiogenic elastin-like recombinamer (ELR)–based hydrogel in a hindlimb ischemia murine model. Human bone marrow MSCs were isolated from four healthy donors, while ELR biomaterials were genetically engineered. Hindlimb ischemia was induced through ligation of the right femoral artery, and mice were intramuscularly injected with ELR biomaterial, 0.5 × 106 MSCs or the combination, and also compared to untreated animals. Tissue perfusion was monitored using laser Doppler perfusion imaging. Histological analysis of hindlimbs was performed after hematoxylin and eosin staining. Immunofluorescence with anti–human mitochondria antibody was used for human MSC detection, and the biomaterial was detected by elastin staining. To analyze the capillary density, immunostaining with an anti–CD31 antibody was performed. Our results show that the injection of MSCs significantly improves tissue reperfusion from day 7 (p = 0.0044) to day 21 (p = 0.0216), similar to the infusion of MSC + ELR (p = 0.0038, p = 0.0014), without significant differences between both groups. After histological evaluation, ELR hydrogels induced minimal inflammation in the injection sites, showing biocompatibility. MSCs persisted with the biomaterial after 21 days, both in vitro and in vivo. Finally, we observed a higher blood vessel density when mice were treated with MSCs compared to control (p<0.0001), but this effect was maximized and significantly different to the remaining experimental conditions when mice were treated with the combination of MSCs and the ELR biomaterial (p < 0.0001). In summary, the combination of an ELR-based hydrogel with MSCs may improve the angiogenic effects of both strategies on revascularization of ischemic tissues.
Collapse
Affiliation(s)
| | - Ana Rico
- Cell Therapy Unit, Hematology Department, University Hospital of Salamanca, Salamanca, Spain
| | - Silvia Preciado
- Cell Therapy Unit, Hematology Department, University Hospital of Salamanca, Salamanca, Spain
- RICORS TERAV, ISCIII, Madrid, Spain
- Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Salamanca, Spain
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
- Department of Medicine and Cancer Research Center, University of Salamanca, Salamanca, Spain
- *Correspondence: Silvia Preciado,
| | | | - Sandra Muntión
- Cell Therapy Unit, Hematology Department, University Hospital of Salamanca, Salamanca, Spain
- RICORS TERAV, ISCIII, Madrid, Spain
- Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Salamanca, Spain
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
- Department of Medicine and Cancer Research Center, University of Salamanca, Salamanca, Spain
| | - Jesús García-Briñón
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
- Departamento de Biología Celular y Patología, Facultad de Medicina, Salamanca, Spain
| | | | - José Carlos Rodríguez-Cabello
- BIOFORGE Lab, University of Valladolid, CIBER-BBN, Valladolid, Spain
- Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Salamanca, Spain
| | - Miguel Pericacho
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
- Renal and Cardiovascular Research Unit, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain
| | - Matilde Alonso
- BIOFORGE Lab, University of Valladolid, CIBER-BBN, Valladolid, Spain
- Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Salamanca, Spain
| | - Fermín Sánchez-Guijo
- Cell Therapy Unit, Hematology Department, University Hospital of Salamanca, Salamanca, Spain
- RICORS TERAV, ISCIII, Madrid, Spain
- Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León, Salamanca, Spain
- Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
- Department of Medicine and Cancer Research Center, University of Salamanca, Salamanca, Spain
| |
Collapse
|
13
|
Toribio-Vázquez C, Perez-Carral J, Trelles C, Cansino R, Fernandez-Pascual E, Mainez J, Yebes A, Ballesteros Ruiz C, Alonso M, Ayllon H, Giron M, Martinez-Piñeiro L. Analysis of our initial experience with AquaBeam® for the treatment of patients with benign prostatic hyperplasia. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)00238-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
14
|
Eeckhoudt J, Bettens T, Geerlings P, Cammi R, Chen B, Alonso M, De Proft F. Conceptual Density Functional Theory under Pressure: Part I. XP-PCM Method Applied to Atoms. Chem Sci 2022; 13:9329-9350. [PMID: 36093025 PMCID: PMC9384819 DOI: 10.1039/d2sc00641c] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Accepted: 07/14/2022] [Indexed: 11/21/2022] Open
Abstract
High pressure chemistry offers the chemical community a range of possibilities to control chemical reactivity, develop new materials and fine-tune chemical properties. Despite the large changes that extreme pressure brings to the table, the field has mainly been restricted to the effects of volume changes and thermodynamics with less attention devoted to electronic effects at the molecular scale. This paper combines the conceptual DFT framework for analyzing chemical reactivity with the XP-PCM method for simulating pressures in the GPa range. Starting from the new derivatives of the energy with respect to external pressure, an electronic atomic volume and an atomic compressibility are found, comparable to their enthalpy analogues, respectively. The corresponding radii correlate well with major known sets of this quantity. The ionization potential and electron affinity are both found to decrease with pressure using two different methods. For the electronegativity and chemical hardness, a decreasing and increasing trend is obtained, respectively, and an electronic volume-based argument is proposed to rationalize the observed periodic trends. The cube of the softness is found to correlate well with the polarizability, both decreasing under pressure, while the interpretation of the electrophilicity becomes ambiguous at extreme pressures. Regarding the electron density, the radial distribution function shows a clear concentration of the electron density towards the inner region of the atom and periodic trends can be found in the density using the Carbó quantum similarity index and the Kullback–Leibler information deficiency. Overall, the extension of the CDFT framework with pressure yields clear periodic patterns. Conceptual DFT has provided a framework in which to study chemical reactivity. Since high pressure is more and more a tool to control reactions and fine-tune chemical properties, this variable is introduced into the CDFT framework.![]()
Collapse
Affiliation(s)
- J Eeckhoudt
- General Chemistry Department (ALGC), Vrije Universiteit Brussel (VUB) Brussels Belgium
| | - T Bettens
- General Chemistry Department (ALGC), Vrije Universiteit Brussel (VUB) Brussels Belgium
| | - P Geerlings
- General Chemistry Department (ALGC), Vrije Universiteit Brussel (VUB) Brussels Belgium
| | - R Cammi
- Department of Chemical Science, Life Science and Environmental Sustainability, University of Parma Parma Italy
| | - B Chen
- Donostia International Physics Center Donostia-San Sebastian Spain
- IKERBASQUE, Basque Foundation for Science Plaza Euskadi 5 48009 Bilbao Spain
| | - M Alonso
- General Chemistry Department (ALGC), Vrije Universiteit Brussel (VUB) Brussels Belgium
| | - F De Proft
- General Chemistry Department (ALGC), Vrije Universiteit Brussel (VUB) Brussels Belgium
| |
Collapse
|
15
|
Conde E, Hernandez S, Caminoa A, Benito A, Martinez R, Alonso M, Jimenez B, Boni V, Remon J, Pijuan L, Clave S, Arriola E, Esteban I, De Castro J, Sansano I, Felip E, Abdulkader I, Garcia J, Rojo F, Domine M, Teixido C, Reguart N, Compañ D, Insa A, Mancheño N, Palanca S, Juan O, Baixeras N, Nadal E, Cebollero M, Calles A, Martin P, Salas C, Provencio M, Aranda I, Massuti B, Lopez-Vilaro L, Majem M, Enguita A, Paz-Ares L, Garrido P, Lopez-Rios F. MA14.02 RET Fusion Testing in Advanced Non-Small Cell Lung Carcinoma Patients: the RETING Study. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
16
|
Juanes-Gusano D, Santos M, Reboto V, Alonso M, Rodríguez-Cabello JC. Self-assembling systems comprising intrinsically disordered protein polymers like elastin-like recombinamers. J Pept Sci 2021; 28:e3362. [PMID: 34545666 DOI: 10.1002/psc.3362] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Revised: 07/02/2021] [Accepted: 07/13/2021] [Indexed: 12/19/2022]
Abstract
Despite lacking cooperatively folded structures under native conditions, numerous intrinsically disordered proteins (IDPs) nevertheless have great functional importance. These IDPs are hybrids containing both ordered and intrinsically disordered protein regions (IDPRs), the structure of which is highly flexible in this unfolded state. The conformational flexibility of these disordered systems favors transitions between disordered and ordered states triggered by intrinsic and extrinsic factors, folding into different dynamic molecular assemblies to enable proper protein functions. Indeed, prokaryotic enzymes present less disorder than eukaryotic enzymes, thus showing that this disorder is related to functional and structural complexity. Protein-based polymers that mimic these IDPs include the so-called elastin-like polypeptides (ELPs), which are inspired by the composition of natural elastin. Elastin-like recombinamers (ELRs) are ELPs produced using recombinant techniques and which can therefore be tailored for a specific application. One of the most widely used and studied characteristic structures in this field is the pentapeptide (VPGXG)n . The structural disorder in ELRs probably arises due to the high content of proline and glycine in the ELR backbone, because both these amino acids help to keep the polypeptide structure of elastomers disordered and hydrated. Moreover, the recombinant nature of these systems means that different sequences can be designed, including bioactive domains, to obtain specific structures for each application. Some of these structures, along with their applications as IDPs that self-assemble into functional vesicles or micelles from diblock copolymer ELRs, will be studied in the following sections. The incorporation of additional order- and disorder-promoting peptide/protein domains, such as α-helical coils or β-strands, in the ELR sequence, and their influence on self-assembly, will also be reviewed. In addition, chemically cross-linked systems with controllable order-disorder balance, and their role in biomineralization, will be discussed. Finally, we will review different multivalent IDPs-based coatings and films for different biomedical applications, such as spatially controlled cell adhesion, osseointegration, or biomaterial-associated infection (BAI).
Collapse
Affiliation(s)
- Diana Juanes-Gusano
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology) CIBER-BBN, Edificio Lucía, University of Valladolid, Valladolid, Spain
| | - Mercedes Santos
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology) CIBER-BBN, Edificio Lucía, University of Valladolid, Valladolid, Spain
| | - Virginia Reboto
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology) CIBER-BBN, Edificio Lucía, University of Valladolid, Valladolid, Spain
| | - Matilde Alonso
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology) CIBER-BBN, Edificio Lucía, University of Valladolid, Valladolid, Spain
| | - José Carlos Rodríguez-Cabello
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology) CIBER-BBN, Edificio Lucía, University of Valladolid, Valladolid, Spain
| |
Collapse
|
17
|
González-Pérez F, Ibáñez-Fonseca A, Alonso M, Rodríguez-Cabello JC. Combining tunable proteolytic sequences and a VEGF-mimetic peptide for the spatiotemporal control of angiogenesis within Elastin-Like Recombinamer scaffolds. Acta Biomater 2021; 130:149-160. [PMID: 34118450 DOI: 10.1016/j.actbio.2021.06.005] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Revised: 05/26/2021] [Accepted: 06/01/2021] [Indexed: 12/16/2022]
Abstract
One of the main challenges in regenerative medicine is the spatiotemporal control of angiogenesis, which is key for the successful repair of many tissues, and determines the proper integration of the implant through the generation of a functional vascular network. To this end, we have designed a three-dimensional (3D) model consisting of a coaxial binary elastin-like recombinamer (ELR) tubular construct. It displays fast and slow proteolytic hydrogels on its inner and outer part, respectively, both sensitive to the urokinase plasminogen activator protease. The ELRs used to build the scaffold included crosslinkable domains to stabilize the structure and a conjugated VEGF-derived peptide (QK) to induce angiogenesis. The mechanical and morphological evaluation of the ELR hydrogels proved their suitability for soft tissue regeneration. In addition, in vitro studies evidenced the effect of the QK peptide on endothelial cell spreading and anastomosis. Moreover, immunohistochemical analyses after subcutaneous implantation of the ELR hydrogels in mice showed the induction of a low macrophage response that resolved over time. The implantation of the 3D model constructs evidenced the ability of the fast proteolytic sequence and the QK peptide to guide cell infiltration and capillary formation in the pre-designed arrangement of the constructs. These results set the basis for the application of this type of scaffolds in regenerative medicine, where spatiotemporally controlled vascularization will help in the promotion of an optimal tissue repair. STATEMENT OF SIGNIFICANCE: Herein, we show the spatiotemporal control of angiogenesis in vivo by the combination of proteolytic sequences, with fast and slow degradation kinetics, and VEGF-mimetic peptide (QK) in a coaxial binary elastin-like recombinamer (ELR) tubular scaffold. These two bioactivities have been previously described for angiogenesis purposes, but have never been combined. This work demonstrates that the bioactivities act synergistically in promoting cell infiltration and subsequent vascularization, thus leading to a controlled evolution in space and time of the vascular microstructure within the hydrogel-like tubular scaffold. This effect has not been showed before and holds great potential for future vascular applications, which might be of great interest for a substantial part of Acta Biomaterialia readership.
Collapse
|
18
|
González-Pérez M, Camasão DB, Mantovani D, Alonso M, Rodríguez-Cabello JC. Biocasting of an elastin-like recombinamer and collagen bi-layered model of the tunica adventitia and external elastic lamina of the vascular wall. Biomater Sci 2021; 9:3860-3874. [PMID: 33890956 DOI: 10.1039/d0bm02197k] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The development of techniques for fabricating vascular wall models will foster the development of preventive and therapeutic therapies for treating cardiovascular diseases. However, the physical and biological complexity of vascular tissue represents a major challenge, especially for the design and the production of off-the-shelf biomimetic vascular replicas. Herein, we report the development of a biocasting technique that can be used to replicate the tunica adventitia and the external elastic lamina of the vascular wall. Type I collagen embedded with neonatal human dermal fibroblast (HDFn) and an elastic click cross-linkable, cell-adhesive and protease-sensitive elastin-like recombinamer (ELR) hydrogel were investigated as readily accessible and tunable layers to the envisaged model. Mechanical characterization confirmed that the viscous and elastic attributes predominated in the collagen and ELR layers, respectively. In vitro maturation confirmed that the collagen and ELR provided a favorable environment for the HDFn viability, while histology revealed the wavy and homogenous morphology of the ELR and collagen layer respectively, the cell polarization towards the cell-attachment sites encoded on the ELR, and the enhanced expression of glycosaminoglycan-rich extracellular matrix and differentiation of the embedded HDFn into myofibroblasts. As a complementary assay, 30% by weight of the collagen layer was substituted with the ELR. This model proved the possibility to tune the composition and confirm the versatile character of the technology developed, while revealing no significant differences with respect to the original construct. On-demand modification of the model dimensions, number and composition of the layers, as well as the type and density of the seeded cells, can be further envisioned, thus suggesting that this bi-layered model may be a promising platform for the fabrication of biomimetic vascular wall models.
Collapse
Affiliation(s)
- Miguel González-Pérez
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid, CIBER-BBN, 47011 Valladolid, Spain.
| | - Dimitria Bonizol Camasão
- Laboratory for Biomaterials and Bioengineering, Canada Research Chair I in Biomaterials and Bioengineering for the Innovation in Surgery, Department of Min-Met-Materials Engineering, Research Center of CHU de Québec, Division of Regenerative Medicine, Laval University, Québec, QC, Canada G1V 0A6
| | - Diego Mantovani
- Laboratory for Biomaterials and Bioengineering, Canada Research Chair I in Biomaterials and Bioengineering for the Innovation in Surgery, Department of Min-Met-Materials Engineering, Research Center of CHU de Québec, Division of Regenerative Medicine, Laval University, Québec, QC, Canada G1V 0A6
| | - Matilde Alonso
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid, CIBER-BBN, 47011 Valladolid, Spain.
| | - José Carlos Rodríguez-Cabello
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid, CIBER-BBN, 47011 Valladolid, Spain.
| |
Collapse
|
19
|
González-Obeso C, González-Pérez M, Mano JF, Alonso M, Rodríguez-Cabello JC. Complex Morphogenesis by a Model Intrinsically Disordered Protein. Small 2020; 16:e2005191. [PMID: 33216415 DOI: 10.1002/smll.202005191] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2020] [Revised: 10/14/2020] [Indexed: 05/13/2023]
Abstract
The development of intricate and complex self-assembling structures in the micrometer range, such as biomorphs, is a major challenge in materials science. Although complex structures can be obtained from self-assembling materials as they segregate from solution, their size is usually in the nanometer range or requires accessory techniques. Previous studies with intrinsically disordered proteins (IDPs) have shown that the active interplay of different molecular interactions provides access to new and more complex nanostructures. As such, it is hypothesized that enriching the variety of intra- and intermolecular interactions in a model IDP will widen the landscape of sophisticated intermediate structures that can be accessed. In this study, a model silk-elastin-like recombinamer capable of interacting via three non-covalent interactions, namely hydrophobic, ion-pairing, and H-bonding is built. This model material is shown to self-assemble into complex stable micrometer-sized biomorphs. Variation of the block composition, pH, and temperature demonstrates the necessary interplay of all three interactions for the formation of such complex structures.
Collapse
Affiliation(s)
- Constancio González-Obeso
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid-CIBER-BBN, Paseo de Belén 19, Valladolid, 47011, Spain
- Department of Biomedical Engineering, Tufts University, 4 Colby St., Medford, MA, 02155, USA
| | - Miguel González-Pérez
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid-CIBER-BBN, Paseo de Belén 19, Valladolid, 47011, Spain
| | - João F Mano
- Department of Chemistry, CICECO - Aveiro Institute of Materials, University of Aveiro, Aveiro, 3810-193, Portugal
| | - Matilde Alonso
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid-CIBER-BBN, Paseo de Belén 19, Valladolid, 47011, Spain
| | - José Carlos Rodríguez-Cabello
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), University of Valladolid-CIBER-BBN, Paseo de Belén 19, Valladolid, 47011, Spain
| |
Collapse
|
20
|
Acosta S, Ye Z, Aparicio C, Alonso M, Rodríguez-Cabello JC. Dual Self-Assembled Nanostructures from Intrinsically Disordered Protein Polymers with LCST Behavior and Antimicrobial Peptides. Biomacromolecules 2020; 21:4043-4052. [PMID: 32786727 PMCID: PMC7558458 DOI: 10.1021/acs.biomac.0c00865] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Antimicrobial peptides (AMPs) have attracted great interest as they constitute one of the most promising alternatives against drug-resistant infections. Their amphipathic nature not only provides them antimicrobial and immunomodulatory properties but also the ability to self-assemble into supramolecular nanostructures. Here, we propose their use as self-assembling domains to drive hierarchical organization of intrinsically disordered protein polymers (IDPPs). Using a modular approach, hybrid protein-engineered polymers were recombinantly produced, thus combining designer AMPs and a thermoresponsive IDPP, an elastin-like recombinamer (ELR). We exploited the ability of these AMPs and ELRs to self-assemble to develop supramolecular nanomaterials by way of a dual-assembly process. First, the AMPs trigger the formation of nanofibers; then, the thermoresponsiveness of the ELRs enables assembly into fibrillar aggregates. The interplay between the assembly of AMPs and ELRs provides an innovative molecular tool in the development of self-assembling nanosystems with potential use for biotechnological and biomedical applications.
Collapse
Affiliation(s)
- Sergio Acosta
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, 47011 Valladolid, Spain
| | - Zhou Ye
- MDRCBB, Minnesota Dental Research Center for Biomaterials and Biomechanics, University of Minnesota, Minneapolis, 55455 Minnesota, United States
| | - Conrado Aparicio
- MDRCBB, Minnesota Dental Research Center for Biomaterials and Biomechanics, University of Minnesota, Minneapolis, 55455 Minnesota, United States
| | - Matilde Alonso
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, 47011 Valladolid, Spain
| | - José Carlos Rodríguez-Cabello
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, 47011 Valladolid, Spain
| |
Collapse
|
21
|
González-Pérez M, González de Torre I, Alonso M, Rodríguez-Cabello JC. Controlled Production of Elastin-like Recombinamer Polymer-Based Membranes at a Liquid-Liquid Interface by Click Chemistry. Biomacromolecules 2020; 21:4149-4158. [PMID: 32852195 DOI: 10.1021/acs.biomac.0c00939] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Diffusion of organic and inorganic molecules controls most industrial and biological processes that occur in a liquid phase. Although significant efforts have been devoted to the design and operation of large-scale purification systems, diffusion devices with adjustable biochemical characteristics have remained difficult to achieve. In this regard, micrometer-scale, bioinspired membranes with tunable diffusion properties have been engineered by covalent cross-linking of two elastin-like recombinamers (ELRs) at a liquid-liquid interface. The covalent approach selected provides the desired ELR-based membranes with structural support, and modulation of the concentration of the polypeptides employed confers direct control of the thickness, pore size, and diffusive properties over a broad range of molecular weights (4-150 kDa). The recombinant and versatile nature of the proteinaceous building blocks employed further paves the way to engineering bioactive motifs within the membrane scaffold, thereby widening their applicability in the biological field.
Collapse
Affiliation(s)
- Miguel González-Pérez
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, 47011 Valladolid, Spain
| | - Israel González de Torre
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, 47011 Valladolid, Spain
| | - Matilde Alonso
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, 47011 Valladolid, Spain
| | - José Carlos Rodríguez-Cabello
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, 47011 Valladolid, Spain
| |
Collapse
|
22
|
Benavent-Albarracín L, Alonso M, Catalán J, Urbaneja A, Davies TGE, Williamson MS, González-Cabrera J. Mutations in the voltage-gated sodium channel gene associated with deltamethrin resistance in commercially sourced Phytoseiulus persimilis. Insect Mol Biol 2020; 29:373-380. [PMID: 32249467 DOI: 10.1111/imb.12642] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Revised: 02/17/2020] [Accepted: 03/30/2020] [Indexed: 06/11/2023]
Abstract
The implementation of Integrated Pest Management in current agricultural practice is a convenient and very effective strategy to keep pest populations under control. The use of biological control agents, such as Phytoseiulus persimilis, is key for the success of such an approach. This predatory mite is widely used as it is very effective for controlling Tetranychus urticae, one of the most devastating crop pests. Here, we identify several mutations located in the voltage-gated sodium channel (VGSC) of commercially sourced P. persimilis that correlate with a reduced susceptibility to the pyrethroid deltamethrin. We found that the mites sourced from two different biocontrol product companies have intrinsic genotypic differences that correlate with their phenotype when tested with different concentrations of deltamethrin. Mites from Syngenta Bioline, carrying the mutations M918L and A1536T, were able to survive deltamethrin concentrations of up to 10 ppm, while the mites from Koppert Biological Systems, with the combination M918L, L925V and S1539T, survived treatment with 40 ppm. All of the point mutations identified in the predatory mite samples are located in a particular region of the VGSC, previously proposed as the binding site for this family of pesticides and identified as a 'hot spot' for resistance.
Collapse
Affiliation(s)
- L Benavent-Albarracín
- Unidad Mixta Gestión Biotecnológica de Plagas UV-IVIA, Department of Genetics, Universitat de València, Estructura de Recerca Interdisciplinar en Biotecnología i Biomedicina (ERI-BIOTECMED), Burjassot, Valencia, Spain
| | - M Alonso
- Unidad Mixta Gestión Biotecnológica de Plagas UV-IVIA, Instituto Valenciano de Investigaciones Agrarias (IVIA), Centro de Protección Vegetal y Biotecnología, Moncada, Valencia, Spain
| | - J Catalán
- Unidad Mixta Gestión Biotecnológica de Plagas UV-IVIA, Instituto Valenciano de Investigaciones Agrarias (IVIA), Centro de Protección Vegetal y Biotecnología, Moncada, Valencia, Spain
| | - A Urbaneja
- Unidad Mixta Gestión Biotecnológica de Plagas UV-IVIA, Instituto Valenciano de Investigaciones Agrarias (IVIA), Centro de Protección Vegetal y Biotecnología, Moncada, Valencia, Spain
| | - T G E Davies
- Biointeractions and Crop Protection Department, Rothamsted Research, Harpenden, Hertfordshire, UK
| | - M S Williamson
- Biointeractions and Crop Protection Department, Rothamsted Research, Harpenden, Hertfordshire, UK
| | - J González-Cabrera
- Unidad Mixta Gestión Biotecnológica de Plagas UV-IVIA, Department of Genetics, Universitat de València, Estructura de Recerca Interdisciplinar en Biotecnología i Biomedicina (ERI-BIOTECMED), Burjassot, Valencia, Spain
| |
Collapse
|
23
|
Ibáñez-Fonseca A, Orbanic D, Arias FJ, Alonso M, Zeugolis DI, Rodríguez-Cabello JC. Influence of the Thermodynamic and Kinetic Control of Self-Assembly on the Microstructure Evolution of Silk-Elastin-Like Recombinamer Hydrogels. Small 2020; 16:e2001244. [PMID: 32519515 DOI: 10.1002/smll.202001244] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/26/2020] [Revised: 04/25/2020] [Indexed: 06/11/2023]
Abstract
Complex recombinant biomaterials that merge the self-assembling properties of different (poly)peptides provide a powerful tool for the achievement of specific structures, such as hydrogel networks, by tuning the thermodynamics and kinetics of the system through a tailored molecular design. In this work, elastin-like (EL) and silk-like (SL) polypeptides are combined to obtain a silk-elastin-like recombinamer (SELR) with dual self-assembly. First, EL domains force the molecule to undergo a phase transition above a precise temperature, which is driven by entropy and occurs very fast. Then, SL motifs interact through the slow formation of β-sheets, stabilized by H-bonds, creating an energy barrier that opposes phase separation. Both events lead to the development of a dynamic microstructure that evolves over time (until a pore size of 49.9 ± 12.7 µm) and to a delayed hydrogel formation (obtained after 2.6 h). Eventually, the network is arrested due to an increase in β-sheet secondary structures (up to 71.8 ± 0.8%) within SL motifs. This gives a high bond strength that prevents the complete segregation of the SELR from water, which results in a fixed metastable microarchitecture. These porous hydrogels are preliminarily tested as biomimetic niches for the isolation of cells in 3D cultures.
Collapse
Affiliation(s)
- Arturo Ibáñez-Fonseca
- BIOFORGE Lab, University of Valladolid - CIBER-BBN. Paseo de Belén 19, Valladolid, 47011, Spain
| | - Doriana Orbanic
- BIOFORGE Lab, University of Valladolid - CIBER-BBN. Paseo de Belén 19, Valladolid, 47011, Spain
| | - Francisco Javier Arias
- BIOFORGE Lab, University of Valladolid - CIBER-BBN. Paseo de Belén 19, Valladolid, 47011, Spain
| | - Matilde Alonso
- BIOFORGE Lab, University of Valladolid - CIBER-BBN. Paseo de Belén 19, Valladolid, 47011, Spain
| | - Dimitrios I Zeugolis
- Regenerative, Modular and Developmental Engineering Laboratory (REMODEL), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, H91 TK33, Ireland
- Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, H91 TK33, Ireland
| | | |
Collapse
|
24
|
Gonzalez de Torre I, Alonso M, Rodriguez-Cabello JC. Elastin-Based Materials: Promising Candidates for Cardiac Tissue Regeneration. Front Bioeng Biotechnol 2020; 8:657. [PMID: 32695756 PMCID: PMC7338576 DOI: 10.3389/fbioe.2020.00657] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2020] [Accepted: 05/27/2020] [Indexed: 11/15/2022] Open
Abstract
Stroke and cardiovascular episodes are still some of the most common diseases worldwide, causing millions of deaths and costing billions of Euros to healthcare systems. The use of new biomaterials with enhanced biological and physical properties has opened the door to new approaches in cardiovascular applications. Elastin-based materials are biomaterials with some of the most promising properties. Indeed, these biomaterials have started to yield good results in cardiovascular and angiogenesis applications. In this review, we explore the latest trends in elastin-derived materials for cardiac regeneration and the different possibilities that are being explored by researchers to regenerate an infarcted muscle and restore its normal function. Elastin-based materials can be processed in different manners to create injectable systems or hydrogel scaffolds that can be applied by simple injection or as patches to cover the damaged area and regenerate it. Such materials have been applied to directly regenerate the damaged cardiac muscle and to create complex structures, such as heart valves or new bio-stents that could help to restore the normal function of the heart or to minimize damage after a stroke. We will discuss the possibilities that elastin-based materials offer in cardiac tissue engineering, either alone or in combination with other biomaterials, in order to illustrate the wide range of options that are being explored. Moreover, although tremendous advances have been achieved with such elastin-based materials, there is still room for new approaches that could trigger advances in cardiac tissue regeneration.
Collapse
|
25
|
Ibáñez-Fonseca A, Santiago Maniega S, Gorbenko del Blanco D, Catalán Bernardos B, Vega Castrillo A, Álvarez Barcia ÁJ, Alonso M, Aguado HJ, Rodríguez-Cabello JC. Elastin-Like Recombinamer Hydrogels for Improved Skeletal Muscle Healing Through Modulation of Macrophage Polarization. Front Bioeng Biotechnol 2020; 8:413. [PMID: 32478048 PMCID: PMC7240013 DOI: 10.3389/fbioe.2020.00413] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2020] [Accepted: 04/14/2020] [Indexed: 12/24/2022] Open
Abstract
Large skeletal muscle injuries, such as a volumetric muscle loss (VML), often result in an incomplete regeneration due to the formation of a non-contractile fibrotic scar tissue. This is, in part, due to the outbreak of an inflammatory response, which is not resolved over time, meaning that type-1 macrophages (M1, pro-inflammatory) involved in the initial stages of the process are not replaced by pro-regenerative type-2 macrophages (M2). Therefore, biomaterials that promote the shift from M1 to M2 are needed to achieve optimal regeneration in VML injuries. In this work, we used elastin-like recombinamers (ELRs) as biomaterials for the formation of non- (physical) and covalently (chemical) crosslinked bioactive and biodegradable hydrogels to fill the VML created in the tibialis anterior (TA) muscles of rats. These hydrogels promoted a higher infiltration of M2 within the site of injury in comparison to the non-treated control after 2 weeks (p<0.0001), indicating that the inflammatory response resolves faster in the presence of both types of ELR-based hydrogels. Moreover, there were not significant differences in the amount of collagen deposition between the samples treated with the chemical ELR hydrogel at 2 and 5 weeks, and this same result was found upon comparison of these samples with healthy tissue after 5 weeks, which implies that this treatment prevents fibrosis. The macrophage modulation also translated into the formation of myofibers that were morphologically more similar to those present in healthy muscle. Altogether, these results highlight that ELR hydrogels provide a friendly niche for infiltrating cells that biodegrades over time, leaving space to new muscle tissue. In addition, they orchestrate the shift of macrophage population toward M2, which resulted in the prevention of fibrosis in the case of the chemical hydrogel treatment and in a more healthy-like myofiber phenotype for both types of hydrogels. Further studies should focus in the assessment of the regeneration of skeletal muscle in larger animal models, where a more critical defect can be created and additional methods can be used to evaluate the functional recovery of skeletal muscle.
Collapse
Affiliation(s)
- Arturo Ibáñez-Fonseca
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, Valladolid, Spain
| | | | - Darya Gorbenko del Blanco
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, Valladolid, Spain
| | | | | | | | - Matilde Alonso
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, Valladolid, Spain
| | - Héctor J. Aguado
- Servicio de Traumatología, Hospital Clínico de Valladolid, Valladolid, Spain
| | - José Carlos Rodríguez-Cabello
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology), CIBER-BBN, University of Valladolid, Valladolid, Spain
| |
Collapse
|
26
|
de Vicente JC, Espinosa C, Rúa-Gonzálvez L, Rodríguez-Santamarta T, Alonso M. Hand perfusion following radial or ulnar forearm free flap harvest for oral cavity reconstruction: A prospective study. Int J Oral Maxillofac Surg 2020; 49:1402-1407. [PMID: 32402690 DOI: 10.1016/j.ijom.2020.04.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2019] [Revised: 03/30/2020] [Accepted: 04/02/2020] [Indexed: 11/18/2022]
Abstract
The radial forearm free flap (RFFF) and ulnar forearm free flap (UFFF) are used in head and neck reconstruction because they provide a thin and pliable skin paddle as well as a long vascular pedicle. However, in spite of several studies showing the safety of the UFFF, the RFFF is more popular among reconstructive surgeons based on concerns about hand ischaemia. A prospective study was designed in which 10 UFFF and 11 RFFF surgeries were performed in 20 patients undergoing oral cavity reconstruction between January 2017 and July 2018. Hand vascular parameters were evaluated preoperatively and postoperatively using Doppler ultrasound and plethysmography. The preoperative and postoperative diameters of the radial and ulnar arteries, and the flow velocities through the remainder of the forearm artery were measured preoperatively and at 3 months postoperative. Additionally, a comparison was performed between the preoperative and postoperative fingertip perfusion values according to impedance plethysmography. The preoperative mean diameter of the radial artery (2.89±0.47mm) was significantly greater than that of the ulnar artery (2.35±0.48mm) at the level of the wrist; however, 3 months after the surgery, the mean diameters of the two arteries did not differ significantly. There were no differences in digital perfusion when a UFFF was used compared with an RFFF.
Collapse
Affiliation(s)
- J C de Vicente
- Department of Maxillofacial Surgery, Hospital Universitario Central de Asturias, University of Oviedo, Asturias, Spain; Instituto de Investigación Sanitaria del Principado de Asturias, Asturias, Spain.
| | - C Espinosa
- Department of Maxillofacial Surgery, Hospital Universitario Central de Asturias, University of Oviedo, Asturias, Spain
| | - L Rúa-Gonzálvez
- Department of Maxillofacial Surgery, Hospital Universitario Central de Asturias, University of Oviedo, Asturias, Spain
| | - T Rodríguez-Santamarta
- Department of Maxillofacial Surgery, Hospital Universitario Central de Asturias, University of Oviedo, Asturias, Spain
| | - M Alonso
- Department of Vascular Surgery, Hospital Universitario Central de Asturias, Asturias, Spain
| |
Collapse
|
27
|
Collazos J, de la Fuente B, de la Fuente J, García A, Gómez H, Menéndez C, Enríquez H, Sánchez P, Alonso M, López-Cruz I, Martín-Regidor M, Martínez-Alonso A, Guerra J, Artero A, Blanes M, Asensi V. Factors associated with sepsis development in 606 Spanish adult patients with cellulitis. BMC Infect Dis 2020; 20:211. [PMID: 32164590 PMCID: PMC7066725 DOI: 10.1186/s12879-020-4915-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2019] [Accepted: 02/21/2020] [Indexed: 11/16/2022] Open
Abstract
Background Cellulitis, a frequent cause of admission of adult patients to medical wards, occasionally evolves to sepsis. In this study we analyze the factors related to sepsis development. Methods Prospective and observational study of 606 adult patients with cellulitis admitted to several Spanish hospitals. Comorbidities, microbiological, clinical, lab, diagnostic, and treatment data were analyzed. Sepsis was diagnosed according to the criteria of the 2016 International Sepsis Definitions Conference. Multiple logistic regression modelling was performed to determine the variables independently associated with sepsis development. Results Mean age was 63.4 years and 51.8% were men. Overall 65 (10.7%) patients developed sepsis, 7 (10.8%) of whom died, but only 4 (6.2%) due to cellulitis. Drawing of blood (P < 0.0001) or any (P < 0.0001) culture, and identification of the agent (P = 0.005) were more likely among patients with sepsis. These patients had also a longer duration of symptoms (P = 0.04), higher temperature (P = 0.03), more extensive cellulitis (P = 0.02), higher leukocyte (P < 0.0001) and neutrophil (P < 0.0001) counts, serum creatinine (P = 0.001), and CRP (P = 0.008) than patients without sepsis. Regarding therapy, patients with sepsis were more likely to undergo changes in the initial antimicrobial regimen (P < 0.0001), received more antimicrobials (P < 0.0001), received longer intravenous treatment (P = 0.03), and underwent surgery more commonly (P = 0.01) than patients without sepsis. Leukocyte counts (P = 0.002), serum creatinine (P = 0.003), drawing of blood cultures (P = 0.004), change of the initial antimicrobial regimen (P = 0.007) and length of cellulitis (P = 0.009) were independently associated with sepsis development in the multivariate analysis. Conclusions Increased blood leukocytes and serum creatinine, blood culture drawn, modification of the initial antimicrobial regimen, and maximum length of cellulitis were associated with sepsis in these patients.
Collapse
Affiliation(s)
- J Collazos
- Infectious Diseases Unit, Hospital de Galdácano, Vizcaya, Spain
| | - B de la Fuente
- Infectious Diseases Unit, Hospital de Cabueñes, Gijón, Spain
| | - J de la Fuente
- Internal Medicine Service, Hospital de Povisa, Vigo, Spain
| | - A García
- Infectious Diseases Unit, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - H Gómez
- Infectious Diseases Unit, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - C Menéndez
- Infectious Diseases Unit, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - H Enríquez
- Internal Medicine Service, Hospital de Povisa, Vigo, Spain
| | - P Sánchez
- Internal Medicine Service, Hospital de Povisa, Vigo, Spain
| | - M Alonso
- Internal Medicine Service, Hospital de Povisa, Vigo, Spain
| | - I López-Cruz
- Internal Medicine Service, Hospital Dr Peset, Valencia, Spain
| | - M Martín-Regidor
- Internal Medicine Service, Complejo Hospitalario de León, León, Spain
| | - A Martínez-Alonso
- Internal Medicine Service, Complejo Hospitalario de León, León, Spain
| | - J Guerra
- Internal Medicine Service, Complejo Hospitalario de León, León, Spain
| | - A Artero
- Internal Medicine Service, Hospital Dr Peset, Valencia, Spain
| | - M Blanes
- Infectious Diseases Unit, Hospital La Fe, Valencia, Spain
| | - V Asensi
- Infectious Diseases Unit, Hospital Universitario Central de Asturias, Oviedo, Spain. .,Group of Translational Research in Infectious Diseases, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
| |
Collapse
|
28
|
Camasão DB, González-Pérez M, Palladino S, Alonso M, Rodríguez-Cabello JC, Mantovani D. Elastin-like recombinamers in collagen-based tubular gels improve cell-mediated remodeling and viscoelastic properties. Biomater Sci 2020; 8:3536-3548. [DOI: 10.1039/d0bm00292e] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The partial substitution of collagen with elastin-like recombinamers in tubular gels improves cell-mediated remodeling, elastic moduli and strength during maturation.
Collapse
Affiliation(s)
- Dimitria Bonizol Camasão
- Laboratory for Biomaterials and Bioengineering
- Canada Research Chair I in Biomaterials and Bioengineering for the Innovation in Surgery
- Department of Min-Met-Materials Engineering
- Research Center of CHU de Québec
- Division of Regenerative Medicine
| | - Miguel González-Pérez
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology)
- CIBER-BBN
- University of Valladolid
- 47011 Valladolid
- Spain
| | - Sara Palladino
- Laboratory for Biomaterials and Bioengineering
- Canada Research Chair I in Biomaterials and Bioengineering for the Innovation in Surgery
- Department of Min-Met-Materials Engineering
- Research Center of CHU de Québec
- Division of Regenerative Medicine
| | - Matilde Alonso
- BIOFORGE (Group for Advanced Materials and Nanobiotechnology)
- CIBER-BBN
- University of Valladolid
- 47011 Valladolid
- Spain
| | | | - Diego Mantovani
- Laboratory for Biomaterials and Bioengineering
- Canada Research Chair I in Biomaterials and Bioengineering for the Innovation in Surgery
- Department of Min-Met-Materials Engineering
- Research Center of CHU de Québec
- Division of Regenerative Medicine
| |
Collapse
|
29
|
Acosta S, Quintanilla L, Alonso M, Aparicio C, Rodríguez-Cabello JC. Correction to “Recombinant AMP/Polypeptide Self-Assembled Monolayers with Synergistic Antimicrobial Properties for Bacterial Strains of Medical Relevance”. ACS Biomater Sci Eng 2019. [DOI: 10.1021/acsbiomaterials.9b01458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
30
|
Salgado M, Sepulveda Sanchez J, del barco S, Pineda E, Fuster J, Navarro Martin M, Herrero Ibañez A, Alonso M, Perez J, Mesia C, Munoz-Langa J, de las Penas Bataller R, Peralta S, Olier C, Pérez-Segura P, Estival A, Carrato C, Saez C, Gil M, Balana C. Extending temozolomide longer than six cycles in glioblastoma: Results of the randomized GEINO-014 trial. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz243.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
31
|
Vaz Salgado MÁ, Rodríguez Sánchez Á, Fernandez Perez I, Quintanar T, Navarro Martin M, Vieito Villar M, Cano J, Gonzalez S, Ros S, Herrero Ibañez A, Ivars M, Lloret M, Alonso M, Moya I, Luque R, Benavides M, Gutiérrez Toribio M, García-Gómez J, Esteban Villarrubia J, Torres Jimenez J. Spanish survey of treatment recommendations for elderly patients with glioblastoma. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz243.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
32
|
Gállego Pérez-Larraya J, Esparragosa I, Puigdelloses M, Idoate M, Alonso M. P08.04 Glioblastoma and Alzheimer pathology: lessons from a single case with practical implications and need for further research. Neuro Oncol 2019. [DOI: 10.1093/neuonc/noz126.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
BACKGROUND
Glioblastoma (GBM) and Alzheimer’s disease (AD) are frequent among the elderly: about 50% of all GBM patients are 65 years or older, and 5–10% of people above this age threshold suffer from AD.
MATERIAL AND METHODS
We describe the case of an elderly patient with newly diagnosed GBM who developed a rapidly progressive severe dementia immediately following concomitant radio-chemotherapy. A purposed retrospective analysis of the surgical sample revealed Alzheimer pathology.
RESULTS
A 69-year old woman with no relevant past-medical history was diagnosed with a right temporo-parietal GBM on May 2017, with wild-type IDH1R132H gene and methylated MGMTP. After complete resection she received radiotherapy (60 Gy in 30 fractions) and concomitant chemotherapy with Temozolomide 75 mg/m2/day. During the last weeks of concomitant radio-chemotherapy and further on the patient developed a progressive neurological worsening with severe cognitive dysfunction, gait impairment and sphincter incontinence, becoming severely disabled and requiring continuous assistance. Brain MRI exams showed no signs of tumor recurrence, with focal white matter changes consisting on T2/FLAIR hyperintensities within the radiation field, enlarged sulci and ventriculomegaly. Underlying infectious and metabolic disorders, non-convulsive epileptic status and normal-pressure hydrocephalus were ruled out. Facing this situation the patient relatives were purposely asked for previous cognitive symptoms, and described very mild complaints of short-term memory loss during the previous year. Aiming at investigating the possibility of an underlying AD, focused examination of the surgical sample revealed the presence of frequent neuritic plaques, a neuropathological hallmark of AD. The patient developed a severe dementia with akinetic mutism by September 2017. Without evidence of tumor recurrence despite lack of adjuvant chemotherapy, she died of aspiration pneumonia on January 2019.
CONCLUSION
A unique retrospective study including elderly GBM patients treated only with surgery revealed that Alzheimer disease pathology was present in 42% of them. This case illustrates the need for actively addressing the previous cognitive status of elderly patients with GBM. Histopathological assessment of Alzheimer pathology might also be considered in this specific population. In positive cases, particularly in those with methylated MGMTP, radiotherapy should be avoided and treatment alone with Temozolomide might be considered.
Collapse
Affiliation(s)
| | | | | | - M Idoate
- Clínica Universidad de Navarra, Pamplona, Spain
| | - M Alonso
- Clínica Universidad de Navarra, Pamplona, Spain
| |
Collapse
|
33
|
Balana C, Sepulveda J, Pineda E, Vaz M, Mesia C, Fuster J, Girones R, Muñoz-Langa J, Navarro M, Alonso M, Gil Gil M, Herrero A, Estival A, Gallego O, Peralta S, Olier C, Pérez-Segura P, Covela M, Martinez García M, Domenech M, Carrato C, Sanz C, Velarde J, Berrocal A, Luque R, De las Peñas R, Del Barco S. P14.58 Extending adjuvant temozolomide longer than six cycles doesn’t add any benefit to glioblastoma patients according to the randomized GEINO-014 TRIAL. Neuro Oncol 2019. [DOI: 10.1093/neuonc/noz126.293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
BACKGROUND
Standard treatment of glioblastoma (GBM) is focal radiation with concomitant and adjuvant temozolomide (TMZ) for 6 cycles. The GEINO-14-01 trial (NCT02209948) investigated the role of extending adjuvant TMZ to 12 cycles in a randomized multicenter study.
MATERIAL AND METHODS
Between Aug/2014 and Nov/2018, 166 patients (p) were screened and 159 randomized to extend (80p) or not (79p) TMZ treatment to 12 cycles after proving stable disease in the MRI performed before inclusion. The trial was stratified by MGMT status and presence or absence of residual disease (defined as a residual enhancement larger than 1cm on the MRI). The primary endpoint was differences in 6monthsPFS, secondary endpoints were differences in PFS, OS, toxicity, between arms and per stratification factors.
RESULTS
Median age was 60.4 (range 29–83), 97p (61%) were methylated and 83 p (52.2%) were reported with residual disease. Median (m) PFS was 7.9 months (95%CI: 6.1–9.8) and mOS: 20.9 (95%CI: 17.6–24.1). A methylated status was a factor of better PFS (HR=0.29, 95% CI 0.46–0.95; p=0.029) and better OS (HR= 0.43: 95% CI 0.28–0.66; p=0.000) as well as the absence of residual disease (PFS: HR = 0.84: 95% CI =0.71–1.01; p=0.068; OS: HR=0.77, 95%CI 0.63–0.96; p=0.019). We didn’t find any difference in PFS (HR=1.02, 95%CI 0.85–1.21; p=0.82), or OS (HR=0.90; 0.73–1.11; p=0.34) on extending treatment with temozolomide longer than 6 cycles.
CONCLUSION
There is no benefit of continuing TMZ treatment for more than 6 cycles in the adjuvant treatment of glioblastoma. Final data will be presented at the congress. Supported by a Grant of the ISCIII: PI13/01751
Collapse
Affiliation(s)
- C Balana
- Institut Catala Oncologia Badalona, Badalona, Spain
| | - J Sepulveda
- Hospital Universitario 12 de Octubre, Madrid, Spain
| | - E Pineda
- Hospital Clinic de Barcelona, Barcelona, Spain
| | - M Vaz
- Hospital Ramon y Cajal, Madrid, Spain
| | - C Mesia
- Institut Catala Oncologia Hospital Duran y Reynalds, Hospitalet de Llobregat, Spain
| | - J Fuster
- Hospital Universitari Son Espases, Palma de Mallorca, Spain
| | - R Girones
- Hospital Universitari i Politècnic la Fe, Valencia, Spain
| | - J Muñoz-Langa
- Hospital Universitari i Politècnic la Fe, Valencia, Spain
| | - M Navarro
- Hospital Universitario de Salamanca, Salamanca, Spain
| | - M Alonso
- Hospital Universitario la Virgen del Rocio, Sevilla, Spain
| | - M Gil Gil
- Institut Catala Oncologia Hospital Duran y Reynalds, Hospitalet de Llobregat, Spain
| | - A Herrero
- Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - A Estival
- Institut Catala Oncologia Badalona, Badalona, Spain
| | - O Gallego
- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - S Peralta
- Hospital Universitari Sant Joan de Reus, Reus, Spain
| | - C Olier
- Hospital Universitario Fundacion Alcorcon, Alcorcon, Spain
| | | | - M Covela
- Hospital Universitario Lucus Augusti, Lugo, Spain
| | | | - M Domenech
- Institut Catala Oncologia Badalona, Badalona, Spain
| | - C Carrato
- Hospital Universitari Germans Trias i Pujol, Badalona, Spain
| | - C Sanz
- Hospital Universitari Germans Trias i Pujol, Badalona, Spain
| | - J Velarde
- Institut Catala Oncologia Badalona, Badalona, Spain
| | - A Berrocal
- Hospital General Universitari de Valencia, Valencia, Spain
| | - R Luque
- HospitalUniversitario Virgen de las Nieves, Granada, Spain
| | | | - S Del Barco
- Institut Catala Oncologia Hospital Universitari Josep Trueta, Girona, Spain
| |
Collapse
|
34
|
González-Tampán R, Alonso M, Arribas L, Hurtós L, López-Urdialez R, Sánchez C, Laquente B, Buxó E, Secanella L, Leiva D, Peiró I. MON-PO395: Nutritional Changes in Borderline Resectable Pancreatic Cancer Patients Along the Oncological Treatment. Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32228-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
35
|
Acosta S, Quintanilla L, Alonso M, Aparicio C, Rodríguez-Cabello JC. Recombinant AMP/Polypeptide Self-Assembled Monolayers with Synergistic Antimicrobial Properties for Bacterial Strains of Medical Relevance. ACS Biomater Sci Eng 2019; 5:4708-4716. [DOI: 10.1021/acsbiomaterials.9b00247] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Sergio Acosta
- Bioforge lab, CIBER-BBN, Edificio LUCIA, University of Valladolid, Paseo Belén 19, Valladolid 47011, Spain
| | - Luis Quintanilla
- Bioforge lab, CIBER-BBN, Edificio LUCIA, University of Valladolid, Paseo Belén 19, Valladolid 47011, Spain
| | - Matilde Alonso
- Bioforge lab, CIBER-BBN, Edificio LUCIA, University of Valladolid, Paseo Belén 19, Valladolid 47011, Spain
| | - Conrado Aparicio
- MDRCBB, Minnesota Dental Research Center for Biomaterials and Biomechanics, University of Minnesota, 16-250A Moos Tower, 515 Delaware Street Southeast, Minneapolis, Minnesota 55455, United States
| | | |
Collapse
|
36
|
Poocza L, Cipriani F, Alonso M, Rodríguez-Cabello JC. Hydrophobic Cholesteryl Moieties Trigger Substrate Cell-Membrane Interaction of Elastin-Mimetic Protein Coatings in Vitro. ACS Omega 2019; 4:10818-10827. [PMID: 31460179 PMCID: PMC6648790 DOI: 10.1021/acsomega.9b00548] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Accepted: 05/15/2019] [Indexed: 06/10/2023]
Abstract
A cellular coating based on hydrophobic interactions of an elastin-like recombinamer (ELR) with the cell membrane is presented. It is well-documented that biophysical properties such as net charge, hydrophobicity, and protein-driven cell-ligand (integrin binding) interactions influence the interaction of polymers, proteins or peptides with model membranes and biological cells. Most studies to enhance membrane-substrate interactions have focused on the introduction of positively charged groups to foster electrostatic interactions with the negatively charged membrane. Herein, we present an antagonistic approach based on ELRs with varying amounts of hydrophobic cholesteryl groups (ELRCTAs). The ability of the membranes to stabilize cholesteryl groups is hypothesized to assist the coordination of hydrophobic ELRs with the membrane. The main objective was to generate a defined cellular coating of a recombinant protein that allows for total sequence control and less host, or batch-to-batch, variation as a substitute for the existing coatings like alginate, polyelectrolytes, collagens, and fibronectin. We used an in vitro cell-binding assay to quantify cell-substrate interactions, showing enhanced cellular recognition and matrix distribution with an increasing number of cholesteryl groups incorporated. These novel materials and the versatile nature of their protein sequence have great potential as cellular markers, drug carriers, or hydrophobic cell-binding domains.
Collapse
Affiliation(s)
- Leander Poocza
- Bioforge, University of Valladolid CIBER-BNN, Paseo de Belén 19, 47011 Valladolid, Spain
| | - Filippo Cipriani
- Technical
Proteins Nanobiotechnology S.L., Paseo de Belén 9A, 47011 Valladolid, Spain
| | - Matilde Alonso
- Bioforge, University of Valladolid CIBER-BNN, Paseo de Belén 19, 47011 Valladolid, Spain
| | | |
Collapse
|
37
|
Martin-Granizo R, Colorado L, Serrano I, Naranjo N, Celotti C, L., Correa D, Alonso M, González A, de Pedro M. Platelet rich plasma in arthroscopy of the tmj. a retrospective single center study. Int J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.ijom.2019.03.543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
38
|
Martin-Granizo R, Ramos E, Celotti C, Naranjo N, Colorado L, Encinas A, Alonso M, Alonso A, De Pedro M. The correlation between wilkes and bronstein-merril classifications after TMJ arthroscopy is moderate after a 800-procedure study. Int J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.ijom.2019.03.544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
39
|
Martín-Granizo R, Ramos E, Celotti C, Naranjo N, Colorado L, Martinez I, Varela E, Alonso M, De Pedro M. Infiltration of botulinum toxin type a associated with arthroscopy in patients with temporomandibular joint dysfunction. Int J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.ijom.2019.03.866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
40
|
Flora T, González de Torre I, Alonso M, Rodríguez-Cabello JC. Use of proteolytic sequences with different cleavage kinetics as a way to generate hydrogels with preprogrammed cell-infiltration patterns imparted over their given 3D spatial structure. Biofabrication 2019; 11:035008. [DOI: 10.1088/1758-5090/ab10a5] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
41
|
Flora T, de Torre IG, Alonso M, Rodríguez-Cabello JC. Tethering QK peptide to enhance angiogenesis in elastin-like recombinamer (ELR) hydrogels. J Mater Sci Mater Med 2019; 30:30. [PMID: 30762134 DOI: 10.1007/s10856-019-6232-z] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/26/2018] [Accepted: 02/03/2019] [Indexed: 06/09/2023]
Abstract
The development of new capillary networks in engineered constructs is essential for their survival and their integration with the host tissue. It has recently been demonstrated that ELR-based hydrogels encoding different bioactivities are able to modulate their interaction with the host after injection or implantation, as indicated by an increase in cell adhesion and the ability to trigger vascularization processes. Accordingly, the aim of this study was to increase their angiogenic ability both in vitro and in vivo using a small VEGF mimetic peptide named QK, which was tethered chemically to ELR-based hydrogels containing cell-adhesion sequences in their backbone, such as REDV and RGD, as well as a proteolytic site (VGVAPG). In vitro studies were performed using a co-culture of endothelial and fibroblast cells encapsulated into the ELR-based hydrogels in order to determine cell proliferation after 21 days of culture, as well as the number of cell-cell interactions. It was found that although the presence of this peptide does not influence the morphological and rheological properties of these hydrogels, it has an effect on cell behaviour, inducing an increase in cell proliferation and the formation of endothelial cell clusters. In vivo studies demonstrate that the QK peptide enhances the formation of prominent functional capillaries at three weeks post-injection, as confirmed by H&E staining and CD31 immunohistochemistry. The newly formed functional microvasculature ensures perfusion and connection with surrounding tissues. These results show that ELR-QK hydrogels increase capillary network formation and are therefore attractive candidates for application in tissue regeneration, for example for the treatment of cardiovascular diseases such as myocardial infarction or ischemia.
Collapse
Affiliation(s)
- Tatjana Flora
- BIOFORGE, CIBER-BBN, Edificio Lucia, Universidad de Valladolid, Paseo Belén 19, 47011, Valladolid, Spain
| | - I González de Torre
- BIOFORGE, CIBER-BBN, Edificio Lucia, Universidad de Valladolid, Paseo Belén 19, 47011, Valladolid, Spain
- Technical proteins nanobiotechnology (TPNBT S.L.), Paseo Belén 9A, 47011, Valladolid, Spain
| | - M Alonso
- BIOFORGE, CIBER-BBN, Edificio Lucia, Universidad de Valladolid, Paseo Belén 19, 47011, Valladolid, Spain
| | - J Carlos Rodríguez-Cabello
- BIOFORGE, CIBER-BBN, Edificio Lucia, Universidad de Valladolid, Paseo Belén 19, 47011, Valladolid, Spain.
| |
Collapse
|
42
|
Testera AM, Santos M, Girotti A, Arias FJ, Báñez JM, Alonso M, Rodríguez-Cabello JC. A novel lipase-catalyzed method for preparing ELR-based bioconjugates. Int J Biol Macromol 2019; 121:752-759. [DOI: 10.1016/j.ijbiomac.2018.10.028] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2018] [Revised: 09/29/2018] [Accepted: 10/08/2018] [Indexed: 11/29/2022]
|
43
|
Hernandez S, Angulo B, Dominguez C, Caminoa A, Muriel A, Alonso M, Jimenez L, Peñalver R, Collazo-Lorduy A, Jimenez B, Garrido P, Paz-Ares L, De Castro J, Conde E, Lopez-Rios F. P2.09-11 TMB Estimated with Targeted NGS in Early Stage Squamous Cell Carcinoma: Correlation with PD-L1 Expression and Lymphocyte Density. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
44
|
Ramos García I, Sanchez Gastaldo A, Barneto I, Ayala P, Berciano M, Bernabé R, Robles M, Collado R, Alonso M, García T, Cobo Dols M, Trigo J. P2.04-24 Nivolumab in the "Real World": Are the Results of Clinical Trials Reproducible? J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1248] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
45
|
Esparragosa I, Inoges S, de Cerio AL, Espinos J, Aristu J, Puigdelloses M, Alonso M, Tejada-Solis S, Díez-Valle R, Gállego Pérez-Larraya J. P01.061 Autologous dendritic cells vaccination and standard radio-chemotherapy in patients with newly diagnosed glioblastoma: a retrospective single-center series. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- I Esparragosa
- Department of Neurology. Clínica Universidad de Navarra, Pamplona, Spain
| | - S Inoges
- Cellular Therapy Laboratory. Clínica Universidad de Navarra, Pamplona, Spain
| | - A L de Cerio
- Department of Neurology. Clínica Universidad de Navarra, Pamplona, Spain
| | - J Espinos
- Department of Radiotherapy & Oncology. Clínica Universidad de Navarra, Pamplona, Spain
| | - J Aristu
- Department of Radiotherapy & Oncology. Clínica Universidad de Navarra, Pamplona, Spain
| | - M Puigdelloses
- Laboratory of Neuro-Oncology. Clínica Universidad de Navarra. CIMA, Pamplona, Spain
| | - M Alonso
- Laboratory of Neuro-Oncology. Clínica Universidad de Navarra. CIMA, Pamplona, Spain
| | - S Tejada-Solis
- Department of Neurosurgery. Clínica Universidad de Navarra, Pamplona, Spain
| | - R Díez-Valle
- Department of Neurosurgery. Clínica Universidad de Navarra, Pamplona, Spain
| | | |
Collapse
|
46
|
Puigdelloses M, González-Huarriz M, Zandio B, Besora S, Bruna J, Petrirena G, Marigil M, Díez-Valle R, Tejada S, Nuñez J, Alonso M, Gállego Pérez-Larraya J. OS1.1 Role of RNU6-1 isolated from circulating exosomes as a differential biomarker for GBM versus non-neoplasic brain lesions and PCNSL. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | | | - B Zandio
- Complejo Hospitalario de Navarra, Pamplona, Spain
| | - S Besora
- Hospital de Bellvitge, Barcelona, Spain
| | - J Bruna
- Hospital de Bellvitge, Barcelona, Spain
| | | | - M Marigil
- Clinica Universidad de Navarra., Pamplona, Spain
| | - R Díez-Valle
- Clinica Universidad de Navarra., Pamplona, Spain
| | - S Tejada
- Clinica Universidad de Navarra., Pamplona, Spain
| | - J Nuñez
- Research support service. Clínica Universidad de Navarra., Pamplona, Spain
| | - M Alonso
- Clinica Universidad de Navarra. CIMA, Pamplona, Spain
| | | |
Collapse
|
47
|
Flora T, de Torre IG, Quintanilla L, Alonso M, Rodríguez-Cabello JC. Spatial control and cell adhesion selectivity on model gold surfaces grafted with elastin-like recombinamers. Eur Polym J 2018. [DOI: 10.1016/j.eurpolymj.2018.06.026] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Costa RR, González-Pérez M, Herrero-Gutiérrez M, Pires RA, Alonso M, Rodriguez-Cabello JC, Reis RL, Pashkuleva I. Tuning the Stiffness of Surfaces by Assembling Genetically Engineered Polypeptides with Tailored Amino Acid Sequence. Biomacromolecules 2018; 19:3401-3411. [DOI: 10.1021/acs.biomac.8b00723] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Rui R. Costa
- 3B’s Research Group, I3Bs−Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal
- ICVS/3B’s, PT Government Associated Laboratory, Braga/Guimarães, Portugal
| | - Miguel González-Pérez
- G.I.R. Bioforge, University of Valladolid, CIBER-BBN, Edificio LUCIA, Paseo de Belén, 19, 47011 Valladolid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) Valladolid, Spain
| | - Marcos Herrero-Gutiérrez
- G.I.R. Bioforge, University of Valladolid, CIBER-BBN, Edificio LUCIA, Paseo de Belén, 19, 47011 Valladolid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) Valladolid, Spain
| | - Ricardo A. Pires
- 3B’s Research Group, I3Bs−Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal
- ICVS/3B’s, PT Government Associated Laboratory, Braga/Guimarães, Portugal
- The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Avepark, 4805-017 Barco, Guimarães, Portugal
| | - Matilde Alonso
- G.I.R. Bioforge, University of Valladolid, CIBER-BBN, Edificio LUCIA, Paseo de Belén, 19, 47011 Valladolid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) Valladolid, Spain
| | - J. Carlos Rodriguez-Cabello
- G.I.R. Bioforge, University of Valladolid, CIBER-BBN, Edificio LUCIA, Paseo de Belén, 19, 47011 Valladolid, Spain
- Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) Valladolid, Spain
| | - Rui L. Reis
- 3B’s Research Group, I3Bs−Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal
- ICVS/3B’s, PT Government Associated Laboratory, Braga/Guimarães, Portugal
- The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Avepark, 4805-017 Barco, Guimarães, Portugal
| | - Iva Pashkuleva
- 3B’s Research Group, I3Bs−Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal
- ICVS/3B’s, PT Government Associated Laboratory, Braga/Guimarães, Portugal
| |
Collapse
|
49
|
Balañá C, Alonso M, Hernandez-Lain A, Perez-Segura P, Pineda E, Ramos A, Sanchez AR, Teixidor P, Verger E, Benavides M. Correction to: SEOM clinical guidelines for anaplastic gliomas (2017). Clin Transl Oncol 2018; 20:937. [PMID: 29858734 DOI: 10.1007/s12094-018-1904-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnostic/prognostic and predictive value of IDH1/IDH2 missense mutations and 1p/19q codeletions in AG. The diagnosis of anaplastic oligoastrocytoma is discouraged. Surgery, radiotherapy and chemotherapy with PCV or TMZ are the first-line standard of care for AG with slight modifications according to molecular variables. A multidisciplinary team is highly recommended in the management of these tumors.
Collapse
Affiliation(s)
- C Balañá
- Institut Català Oncologia Badalona, Ct. Canyet, s/n, 08916, Barcelona, Spain.
| | - M Alonso
- Complejo Hospitalario Virgen del Rocío, Seville, Spain
| | | | - P Perez-Segura
- Hospital Universitario Clínico San Carlos, Madrid, Spain
| | - E Pineda
- Hospital Clínic i Provincial, Barcelona, Spain
| | - A Ramos
- Hospital 12 de Octubre, Madrid, Spain
| | - A R Sanchez
- Complejo Asistencial Universitario de León, León, Spain
| | - P Teixidor
- Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain
| | - E Verger
- Hospital Clínic i Provincial, Barcelona, Spain
| | - M Benavides
- Hospital Universitario Regional y Virgen de la Victoria, Málaga, Spain
| |
Collapse
|
50
|
González de Torre I, Ibáñez-Fonseca A, Quintanilla L, Alonso M, Rodríguez-Cabello JC. Random and oriented electrospun fibers based on a multicomponent, in situ clickable elastin-like recombinamer system for dermal tissue engineering. Acta Biomater 2018; 72:137-149. [PMID: 29574183 DOI: 10.1016/j.actbio.2018.03.027] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2017] [Revised: 02/20/2018] [Accepted: 03/14/2018] [Indexed: 10/17/2022]
Abstract
Herein we present a system to obtain fibers from clickable elastin-like recombinamers (ELRs) that crosslink in situ during the electrospinning process itself, with no need for any further treatment to stabilize them. These ELR-click fibers are completely stable under in vitro conditions. A wrinkled fiber morphology is obtained. In addition to a random fiber orientation, oriented fibers with a high degree of alignment and coherence can also be obtained by using a rotational electrode. The production of multicomponent fibers means that different functionalities, such as cell-adhesion domains (RGD peptides), can be incorporated into them. In a subsequent study, two main cell lines present in the dermis and epidermis, namely keratinocytes and fibroblasts, were cultured on top of the ELR-click fibers. Adhesion, proliferation, fluorescence, immunostaining and histology studies showed the cytocompatibility of these scaffolds, thus suggesting their possible use for wound dressings in skin tissue engineering applications. STATEMENT OF SIGNIFICANCE For the first time stable electrospun bioactive fibers are obtained by the in situ mixing of two "clickable" ELR components previously described by Gonzalez et al (Acta Biomaterialia 2014). This work describes an efficient system to prepare fibrous scaffolds based on peptidic polymers by electrospinning without the need of crosslinking agents that could be harmful for cells or living tissues. These bioactive fibers support cell growth due to the inclusion of RGD motifs (Staubli et al. Biomaterials 2017). Finally, the in vitro biocompatibility of the two main cell types found in the outer layers of skin, fibroblasts and keratinocytes, indicates that this system is of great interest to prepare elastic artificial skin substitutes for wound healing applications.
Collapse
|